Literature DB >> 16462765

Trp53-dependent DNA-repair is affected by the codon 72 polymorphism.

M Siddique1, K Sabapathy.   

Abstract

Trp53 is arguably the most critical tumour suppressor gene product that inhibits malignant transformation. Besides mutations that inactivate Trp53 functions, genetic polymorphisms have been suggested to be risk factors for cancer. A polymorphic site at codon 72 in exon 4 encodes either an arginine amino acid (Trp53(72R)) or a proline residue (Trp53(72P)). Previous studies have shown that the Trp53(72R) form is more efficient in apoptosis induction, whereas the Trp53(72P) form was suggested to induce G1 arrest better. Here we report that Trp53(72P) is more efficient than Trp53(72R) in specifically activating several Trp53-dependent DNA-repair target genes in several cellular systems. Moreover, using isogenic cell lines and several DNA-repair assays, we show that Trp53(72P) cells have a significantly higher DNA-repair capacity than the Trp53(72R) cells. Furthermore, Trp53(72P)-expressing cells exhibit reduced micronuclei formation compared to Trp53(72R)-expressing cells, suggesting that genomic instability is reduced in these cells. Together, the data highlight the functional differences between the Trp53 polymorphic variants, and suggest that their expression status may influence cancer risk.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16462765     DOI: 10.1038/sj.onc.1209405

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  50 in total

1.  Genetic variants of the p53 and p73 genes jointly increase risk of second primary malignancies in patients after index squamous cell carcinoma of the head and neck.

Authors:  Yang Zhang; Erich M Sturgis; Zhigang Huang; Mark E Zafereo; Qingyi Wei; Guojun Li
Journal:  Cancer       Date:  2011-06-29       Impact factor: 6.860

2.  Association between polymorphisms in tumor suppressor genes and oncogenes and risk of hepatocellular carcinoma: a case-control study in an HCC epidemic area within the Han Chinese population.

Authors:  Chenghao Su; Yong Lin; Jianjun Niu; Lin Cai
Journal:  Med Oncol       Date:  2014-11-21       Impact factor: 3.064

3.  Association between the TP53 Arg72Pro polymorphism and clinical outcomes in acute myeloid leukemia.

Authors:  Matheus F Bezerra; Juan L Coelho-Silva; Jessica C Nascimento; Mariana T Benicio; Cintia R Rocha; Cintia G Machado; Eduardo M Rego; Marcos A Bezerra; Antonio R Lucena-Araujo; Eduardo I Beltrão
Journal:  Haematologica       Date:  2016-10-20       Impact factor: 9.941

4.  Assessment of the XPC (A2920C), XPF (T30028C), TP53 (Arg72Pro) and GSTP1 (Ile105Val) polymorphisms in the risk of cutaneous melanoma.

Authors:  Cristiane Oliveira; José Augusto Rinck-Junior; Gustavo Jacob Lourenço; Aparecida Machado Moraes; Carmen Silvia Passos Lima
Journal:  J Cancer Res Clin Oncol       Date:  2013-04-09       Impact factor: 4.553

5.  P53 gene polymorphisms and breast cancer risk in Arab women.

Authors:  Shafika Alawadi; Lina Ghabreau; Mervat Alsaleh; Zainab Abdulaziz; Mohamed Rafeek; Nizar Akil; Moussa Alkhalaf
Journal:  Med Oncol       Date:  2010-05-05       Impact factor: 3.064

6.  p53 Pro72Arg polymorphism and prostate cancer in men of African descent.

Authors:  L Ricks-Santi; T Mason; V Apprey; C Ahaghotu; A McLauchlin; D Josey; G Bonney; G M Dunston
Journal:  Prostate       Date:  2010-12-01       Impact factor: 4.104

7.  The association between polymorphism of P53 Codon72 Arg/Pro and hepatocellular carcinoma susceptibility: evidence from a meta-analysis of 15 studies with 3,704 cases.

Authors:  Surong Hu; Lianying Zhao; Jingting Yang; Miao Hu
Journal:  Tumour Biol       Date:  2013-12-11

8.  Molecular epidemiology of genetic susceptibility to gastric cancer: focus on single nucleotide polymorphisms in gastric carcinogenesis.

Authors:  Ming Yin; Zhibin Hu; Dongfeng Tan; Jaffer A Ajani; Qingyi Wei
Journal:  Am J Transl Res       Date:  2009-01-01       Impact factor: 4.060

9.  Germline mutations and polymorphisms in the origins of cancers in women.

Authors:  Kim M Hirshfield; Timothy R Rebbeck; Arnold J Levine
Journal:  J Oncol       Date:  2010-01-10       Impact factor: 4.375

10.  Validation of dot blot hybridization and denaturing high performance liquid chromatography as reliable methods for TP53 codon 72 genotyping in molecular epidemiologic studies.

Authors:  Tatiana Rabachini; Helen Trottier; Eduardo L Franco; Luisa L Villa
Journal:  BMC Genet       Date:  2010-05-26       Impact factor: 2.797

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.